Lifog (Latanoprost)

Latanoprost is a prostaglandin F₂α analogue that binds to FP receptors in the eye. This binding remodels extracellular matrix proteins, increasing uveoscleral outflow of aqueous humor. The enhanced outflow lowers intra‑ocular pressure, providing sustained pressure control after once‑daily topical application.

The prescribed regimen for Lifog is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing are individualized based on the patient’s intra‑ocular pressure response and clinical judgment.

Safety data for latanoprost in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be used only if the potential benefit justifies the possible risk to the fetus or infant, and the decision should be made by the prescriber.

To request Lifog, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and necessary import documentation.

Lifog (latanoprost) belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and a strong IOP‑lowering effect. Compared with beta‑blocker eye drops such as timolol, latanoprost often provides greater pressure reduction and a more convenient dosing schedule, though individual response and side‑effect profiles vary.

Lifog should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from direct light and moisture, and keep the cap tightly closed when not in use. Do not freeze the product, and discard any solution that appears discolored or contaminated.

Lifog is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac without touching the bottle tip to the eye. Close the eye gently for a few seconds and avoid blinking excessively.

Serious adverse events, although rare, include ocular inflammation such as uveitis or iritis, severe eye pain accompanied by vision loss due to hypotony or corneal edema, and systemic allergic reactions that may manifest as swelling, rash, or anaphylaxis. Any of these symptoms require immediate medical evaluation.

Lifog is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, and it should be avoided in eyes with active intra‑ocular inflammation (e.g., uveitis). Caution is also advised for individuals with severe corneal disease, recent ocular surgery, or those who are pregnant or breastfeeding unless the benefit outweighs the risk.